GE HealthCare Technologies Inc. (NASDAQ:GEHC) Stock Holdings Lessened by Sheaff Brock Investment Advisors LLC

Sheaff Brock Investment Advisors LLC decreased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 70.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,661 shares of the company’s stock after selling 8,700 shares during the quarter. Sheaff Brock Investment Advisors LLC’s holdings in GE HealthCare Technologies were worth $286,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in GEHC. Blue Trust Inc. increased its stake in shares of GE HealthCare Technologies by 9.9% in the third quarter. Blue Trust Inc. now owns 2,334 shares of the company’s stock valued at $219,000 after purchasing an additional 210 shares during the period. Raymond James & Associates raised its stake in GE HealthCare Technologies by 10.4% during the 3rd quarter. Raymond James & Associates now owns 421,356 shares of the company’s stock valued at $39,544,000 after acquiring an additional 39,654 shares in the last quarter. Resonant Capital Advisors LLC acquired a new position in GE HealthCare Technologies during the 3rd quarter worth $201,000. Allspring Global Investments Holdings LLC increased its holdings in shares of GE HealthCare Technologies by 2.3% during the third quarter. Allspring Global Investments Holdings LLC now owns 24,693 shares of the company’s stock valued at $2,317,000 after purchasing an additional 562 shares during the period. Finally, Koss Olinger Consulting LLC acquired a new position in shares of GE HealthCare Technologies during the third quarter valued at $241,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Trading Down 1.4 %

Shares of GEHC opened at $92.21 on Tuesday. GE HealthCare Technologies Inc. has a 1-year low of $74.51 and a 1-year high of $94.80. The business’s 50-day moving average price is $84.24 and its 200 day moving average price is $85.60. The stock has a market capitalization of $42.13 billion, a P/E ratio of 25.33, a P/E/G ratio of 2.93 and a beta of 1.15. The company has a current ratio of 1.23, a quick ratio of 0.98 and a debt-to-equity ratio of 1.12.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping the consensus estimate of $1.26 by $0.19. The business had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. Analysts expect that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th were paid a dividend of $0.035 per share. The ex-dividend date was Tuesday, January 14th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.15%. This is a positive change from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.85%.

Analysts Set New Price Targets

GEHC has been the subject of a number of recent analyst reports. Citigroup increased their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, February 13th. Wells Fargo & Company raised their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday. Finally, Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their target price for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, three have given a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $97.67.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.